Back to search

United Kingdom· GB-APID-34588311000001108

Terlipressin 1mg/8.5ml solution for injection ampoules

A terlipressin product containing terlipressin, registered in United Kingdom by Flynn Pharma Ltd. The same ATC class is registered in 15 of our 19 countries.

ATC H01BA04

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedTerlipressin 1mg/8.5ml solution for i…ATCH01BA04REGISTER NO.GB-APID-3458831100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Terlipressin is registered in 15 of 19 countries.

Countries holding a registration under ATC H01BA04 (terlipressin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 9 of them publish a price we can compare per daily dose

Terlipressin · ATC H01BA04

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Terlipressin
Manufacturer
Flynn Pharma Ltd
Country
United Kingdom (GB)
ATC code
H01BA04
ATC class
Terlipressin
Defined daily dose
12 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5060106551528

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Terlipressin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terlipressin products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Glycylpressin, Terlipressinacetat Ever Pharma
  • Bulgaria · Терлипресин Ацетат Ever Pharma
  • Czechia · Remestyp, Terlipresin Acetát Ever Pharma
  • Germany · Glycylpressin, Terlipressinacetat Ever Pharma
  • Spain · Terlipresina Acetato Ever Pharma
  • France · Acetate De Terlipressine Ever Pharma
  • Hungary · Glypressin
  • Ireland · Terlipressin Acetate Ever Pharma
  • Italy · Glipressina, Terlipressina Acetato Ever Pharma
  • Poland · Terlipressini Acetas Ever Pharma
  • Portugal · Glypressine, Terlipressina Ever Pharma
  • Romania · Acetat De Terlipresină Ever Pharma
  • Slovakia · Remestyp, Terlipresín Ever Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e5135070-b3fe-43a1-aa64-fed65a14535a
GET /v1/drugs/e5135070-b3fe-43a1-aa64-fed65a14535a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "34588311000001108",
  "desc": "Terlipressin 1mg/8.5ml solution for injection ampoules (Flynn Pharma Ltd)",
  "form": "Solution for injection",
  "vpid": "18024611000001101",
  "source": "dmd",
  "vtm_id": "777717004",
  "strength": "120 microgram",
  "substance": "Terlipressin",
  "ingredient": "Terlipressin acetate",
  "supplier_code": "3303501000001106"
}

See everything about terlipressin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.